Mitokinin LLC logo

Mitokinin LLC.

Mitokinin is a biotechnology company, developing targeted therapies for mitochondria-associated disorders, with particular focus on parkinsons disease and certain forms of cardiomyopathy.

Based on the research conducted by the UCSF team led by Shokat, a Howard Hughes Medical Institute Investigator and Nicholas Hertz Ph-D also the co-founder of the company.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.mitokinin.com
Founded2012
Disease Focus
Development Stage
STOCK CODENon Listed
Address
45 Broadway Ste 1440, NY, 10006-3794
New York
United States
Email
Contact Number
+1 347-668-8061

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/mitokinin-llc” connections=”true” suffix=””]

Mitokinin is using a medicinal chemistry effort to generate kinetin analogs optimized for activating PINK1. PINK1 a mitochondrial serine/threonine-protein kinase which causes the parkin protein to bind to depolarized mitochondria to induce autophagy of those mitochondria as they are linked with neurodegeneration.